WIXOM, Mich., May 4, 2010 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, today announced that Robert Chioini, Chief Executive Officer, along with Dr. Richard Yocum, VP Drug Development & Medical Affairs will present at the JMP Securities Research Conference at the Ritz-Carlton Hotel in San Francisco. Dr. Ajay Gupta, Chief Scientific Officer, will be present at the conference as well.
Rockwell Medical To Present At The Ninth Annual JMP Securities Research Conference
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.